Nalley Lisa A 4

4 · BrightSpring Health Services, Inc. · Filed Mar 6, 2026

AI-generated summary of this filing

Updated Mar 7, 2026

BrightSpring (BTSG) Lisa Nalley Sells 30,000 Shares, Exercises Options

What Happened

Lisa A. Nalley, Chief of Staff and Senior Vice President, Human Resources at BrightSpring (BTSG), exercised stock options and sold 30,000 shares. On March 4, 2026 she exercised options at $6.37 per share (cost $191,100) and sold those 30,000 shares in a registered public offering the same day at $41.15 per share for proceeds of $1,234,500. She was also granted restricted stock units (21,354 RSUs) on March 5, 2026 and had several performance-based option awards vest (multiple derivative/award entries dated March 4–5, 2026).

Key Details

Transaction dates and prices:
- 2026-03-04: Exercised 30,000 options at $6.37 (total $191,100).
- 2026-03-04: Sold 30,000 shares in a registered offering at $41.15 ($1,234,500) — sale per footnote F1.
- 2026-03-05: Granted 21,354 RSUs (no cash cost) that vest in three equal annual installments starting Jan 25, 2027 (footnote F2).
- Additional March 4–5 entries reflect vesting/settlement of prior performance-based options (2019 and 2020 awards), some now fully vested (see footnotes F3–F5); some options/awards vest in three equal annual installments beginning Jan 25, 2027 (F6).
Shares owned after the transactions: not specified in the excerpted data — see the full Form 4 for total holdings.
Notable footnotes: sale executed pursuant to a registered public offering (F1); RSUs vest over three years (F2); 2019 and 2020 performance options vested because performance conditions were satisfied on March 4, 2026 and are fully vested (F3–F5).
Filing timeliness: Form filed March 6, 2026 reporting transactions through March 5, 2026; this appears to be within the standard Form 4 reporting window.

Context

The sequence (exercise of options followed by same-day sale in a registered offering) effectively monetized vested option gains and is a common pattern when insiders convert option value to cash. The filing also documents new RSUs (future shares subject to vesting) and the vesting/settlement of performance-based options awarded in prior years. These awards/vests reflect internal compensation events rather than an open-market purchase (so they are not direct bullish purchases of new shares).

Form 4

Period: 2026-03-04

See Remarks

Transactions

Exercise/Conversion
Common Stock
2026-03-04$6.37/sh+30,000$191,100→ 140,594 total
Sale
Common Stock
[F1]
2026-03-04$41.15/sh−30,000$1,234,500→ 110,594 total
Award
Common Stock
[F2]
2026-03-05+21,354→ 131,948 total
Award
Stock Options (Right to Buy)
[F3]
2026-03-04+35,331→ 106,909 total
Exercise: $6.37Exp: 2029-09-24→ Common Stock (35,331 underlying)
Award
Stock Options (Right to Buy)
[F4]
2026-03-04+3,925→ 15,702 total
Exercise: $7.01Exp: 2030-05-12→ Common Stock (3,925 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
[F5]
2026-03-04−30,000→ 76,909 total
Exercise: $6.37Exp: 2029-09-24→ Common Stock (30,000 underlying)
Award
Stock Options (Right to Buy)
[F6]
2026-03-05+52,344→ 52,344 total
Exercise: $41.77Exp: 2036-03-05→ Common Stock (52,344 underlying)

Footnotes (6)

[F1]These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on March 4, 2026, at a price of $41.15, before deducting underwriting discounts and commissions.
[F2]On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2027. Each RSU represents a contingent right to receive one share of common stock upon settlement.
[F3]No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2019 Performance Options") previously awarded to the Reporting Person on September 24, 2019, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2019 Performance Options are fully vested.
[F4]No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2020 Performance Options") previously awarded to the Reporting Person on May 12, 2020, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2020 Performance Options are fully vested.
[F5]These options are fully vested.
[F6]Options vest in three equal annual installments commencing on January 25, 2027.

Signature

/s/ Jennifer Phipps, as Attorney-in-Fact|2026-03-06

1 file